'Global collaboration is the cornerstone of scientific advancement.
Frontiers in Immunology has organized a series of special edition Research Topics, with the goal of highlighting the latest advancements in Translational Immunology across the globe, showcasing the academic excellence and high-quality work of internationally recognized researchers.
These collections aim to shed light on the recent progress made across the entire breadth of the Translational Immunology field and reflect on the future challenges faced by researchers across borders.
Please note, contributions to the collection are by invitation only. Please inform the Editorial Office at immunology@frontiersin.org once you are prepared to submit.’
Dr Beata Derfalvi has received funding from the Canadian Agency for Drugs & Technologies in Health (CADTH) and CSL Behring. She is also on the advisory board for SOBI, Sanofi Genzyme, Novartis
'Global collaboration is the cornerstone of scientific advancement.
Frontiers in Immunology has organized a series of special edition Research Topics, with the goal of highlighting the latest advancements in Translational Immunology across the globe, showcasing the academic excellence and high-quality work of internationally recognized researchers.
These collections aim to shed light on the recent progress made across the entire breadth of the Translational Immunology field and reflect on the future challenges faced by researchers across borders.
Please note, contributions to the collection are by invitation only. Please inform the Editorial Office at immunology@frontiersin.org once you are prepared to submit.’
Dr Beata Derfalvi has received funding from the Canadian Agency for Drugs & Technologies in Health (CADTH) and CSL Behring. She is also on the advisory board for SOBI, Sanofi Genzyme, Novartis
